Evenity (Romosozumab)

Romosozumab is a medicine for osteoporosis, a condition that makes bones thin and easy to break, in women after menopause. It is given as shots under the skin once a month for one year. It works by blocking a protein called sclerostin so the body builds new bone.

Brand names:Evenity
Medication

What people taking Evenity (Romosozumab) report

Every report comes from a Lived member, sent anonymously.

Have you tried Evenity (Romosozumab) for Postmenopausal Osteoporosis?

NameHow it went

About Evenity (Romosozumab)

What It's For

Romosozumab, sold as Evenity, is a prescription injection for osteoporosis, the thinning and weakening of bone that makes fractures more likely. In the US it is approved for women after menopause who are at high risk of breaking a bone, either because they have already had a fracture from osteoporosis or because they have several risk factors, and for those whose other osteoporosis medicines did not work or could not be tolerated. It is one of a small group of bone-building medicines, used when a person needs to gain bone quickly rather than only slow its loss. It is not for women who could still become pregnant, and it has not been studied enough in children to be used for them.

How It Works

Bone is constantly being broken down and rebuilt. Sclerostin is a protein that acts as a brake on the cells that build new bone. Romosozumab is a monoclonal antibody, a lab-made protein that attaches to sclerostin and blocks it. With the brake released, bone-forming cells become more active, and bone breakdown also slows somewhat. The result is new bone in both the spongy interior of bones and their hard outer shell, which raises bone mineral density and lowers fracture risk. This building effect fades after about a year, which is why treatment has a fixed length.

Dosage & Administration

Evenity is given by a healthcare provider, usually in a clinic, once a month for 12 months. Each monthly dose is two injections under the skin, given one after the other, in the belly, thigh or upper arm. Calcium and vitamin D are taken every day during treatment, because building bone draws on calcium and the medicine can lower blood calcium levels. If a monthly dose is missed, it is rescheduled as soon as possible, and later doses are then planned a month apart from that date. After the 12 doses, most people move on to a medicine that slows bone breakdown, such as alendronate (a bisphosphonate pill) or denosumab (Prolia, an injection every six months), to hold on to the bone that was gained.

Side Effects

Joint pain and headache are the most common side effects. Some people also notice muscle cramps, or pain, redness or swelling where the injections were given. Romosozumab may raise the risk of a heart attack or stroke. Chest pain or pressure, shortness of breath, light-headedness, sudden numbness or weakness in the face, arm or leg, difficulty talking, or sudden changes in vision or balance need emergency care: call 911. Swelling of the face, lips, tongue or throat, or trouble breathing or swallowing, can signal a serious allergic reaction and also needs emergency care. Muscle spasms or twitching, or tingling in the fingers, toes or around the mouth, can mean blood calcium has dropped too low; contact the care team right away. Rarely, the thigh bone can break with little or no injury. New or unusual pain in the thigh, hip or groin, often a dull ache for weeks beforehand, should be reported so it can be checked.

Interactions & Warnings

Evenity carries a boxed warning, the most serious warning the US Food and Drug Administration (FDA) puts on a medicine's label, because it may increase the risk of heart attack, stroke and death from heart or blood vessel disease. In a trial comparing it with alendronate, more women on romosozumab had one of these events. It should not be started in someone who has had a heart attack or stroke in the past year, and it is stopped if one happens during treatment. For people with other heart risks, such as heart disease, diabetes, high blood pressure or smoking, the prescriber weighs that risk against the fracture risk. Low blood calcium must be corrected before the first dose. People with severe kidney disease or on dialysis are more likely to develop low calcium and need closer blood tests. Like other strong bone medicines, romosozumab has been linked rarely to osteonecrosis of the jaw, an area of jawbone that does not heal, usually after a tooth extraction or infection. A mouth exam before starting, good dental care and telling the dentist about the treatment before dental work all help. The risk is higher alongside cancer treatment, steroids, or other bone medicines such as bisphosphonates or denosumab. Tell the prescriber about every medicine and supplement you take.

What to Expect

Romosozumab works faster than most osteoporosis medicines. In the main trials, it cut new spine fractures during the first year to about a quarter of the rate seen with placebo, and women who had a year of romosozumab before switching to alendronate had fewer fractures over the following years than women who took alendronate alone. Bone density scans typically show a clear gain after the year of treatment. The course has a defined end. After 12 monthly visits, the gained bone is lost again without a follow-on medicine, so planning that next step is part of starting. Expect monthly appointments, daily calcium and vitamin D, a calcium blood test when the care team asks for one, and a bone density scan to measure how well it worked.

Questions to Ask Your Doctor

  1. 1.Why is a bone-building medicine like romosozumab a better fit for me than a bisphosphonate, denosumab or teriparatide?
  2. 2.Given my heart health and any history of heart attack or stroke, how do my fracture risk and my heart risk compare?
  3. 3.How much calcium and vitamin D should I take, and will my blood calcium be checked?
  4. 4.Should I see a dentist before starting, and what should I do if I need dental work during the year?
  5. 5.Which medicine will I take after the 12 doses, and how will we measure whether the treatment worked?

Last reviewed • Oct 2026

Educational content, not medical advice.